CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

GSK shares rise as $2.5B cost-cutting plan unveiled

Positive
AI Analysis

Summary

GSK announced a $2.5 billion cost-cutting restructuring plan while recording $2.4 billion in impairment charges for Q2, with shares rising on the restructure announcement.

Importance:3/10
Sentiment:
0.30
restructuringcost-cuttingimpairment chargesquarterly results
Related Companies

Read the original article

Published by BioSpace on July 28, 2026 2:27 PM

Read Original